PATENT CLAIM ANALYSIS

Application Number: 15773524
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.

Claim (Index 8):
A recombinant virulence attenuated Gram-negative bacterial strain, wherein the recombinant virulence attenuated Gram-negative bacterial strain is deficient in the production of at least one bacterial effector protein which is virulent toward eukaryotic cells or is deficient in the production of at least one bacterial protein which is part of a secretion system machinery, for use in a method of treating a malignant solid tumor in a subject, wherein the recombinant virulence attenuated Gram-negative bacterial strain accumulates in the malignant solid tumor, the method comprising administering to the subject said recombinant virulence attenuated Gram-negative bacterial strain, wherein the recombinant virulence attenuated Gram-negative bacterial strain is administered in an amount that is sufficient to treat the subject.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15039116', '13364437', '10818071', '15565609', '09763620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6911939688652825
- 35 USC 102 Novelty (BERT): 0.5207036643123956
- Combined Prediction Score: 0.6741449384099938
- Mean Citation Score: 279.251184
- Max Citation Score: 299.61252
- Similarity Product: 210.47045125360248

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test